Wearable sweat sensor for monitoring lactate in the ICU
Part of Infections clinical trials.
This study is testing a wearable sweat sensor to check lactate levels in the sweat of critically ill patients. If the sensor works well, it could offer a less invasive way to monitor patient health compared to blood tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be staying in a surgical intensive care unit (ICU) at the hospital.
- Your blood lactate level must be above 1.5 mmol/L (a sign of stress or illness).
- You must be at least 16 years old.
- You must agree to provide samples and sign a consent form.
- You cannot be pregnant, have a blood disease, have a weakened immune system, or have skin that is too dry for sweat collection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a wearable sensor system in intensive care patients to see if it can predict sepsis early. Sepsis is a life-threatening reaction to infection, and catching it sooner could lead to faster treatment.
This study measures how quickly a blood marker called lactate rises or falls in people with septic shock. It may help doctors understand which patterns are linked to recovery and guide better treatment decisions.
This study uses a wearable skin patch placed on you during a sepsis hospital stay to help predict whether you might need to be readmitted after discharge. It may help doctors identify who is at higher risk of rehospitalization and plan follow-up care earlier.
This trial tests whether a quick genetic test can help doctors choose the right treatment for patients with a suspected severe infection (sepsis) more quickly. The goal is to improve recovery by personalizing care based on your body's response.
This study compares two blood test measurements (neutrophil/lymphocyte ratio and lactate/albumin ratio) to see which better predicts how severe an infection is in ICU patients with sepsis. It aims to find a simpler way to track inflammation.
This study monitors tiny blood vessels under the tongue using a non-invasive device to see how well blood flows in ICU patients on a breathing machine. Researchers hope to improve care for patients with serious infections or shock.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.